MedTrace Logo

Epileptiform Potential of Fully Immersive Virtual Reality

NCT07451093 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2026-05-06

No results posted yet for this study

Summary

The goal of this interventional study is to determine if the use of virtual reality headsets results in an increased risk of seizure in adolescent and adult individuals with epilepsy. The main question it aims to answer are:

\- does use of virtual reality headsets with hand controllers result in a higher risk of seizure compared to use of virtual reality headsets without hand controllers Participants will be asked to wear a virtual reality headset during continuous video EEG recording and EEG with be evaluated during three phases: with display turned off, with display turned on without hand controllers, and with display turned on with hand controllers.

Conditions

Interventions

OTHER

Virtual Reality Headset, display off

15 minutes of EEG recording with VR headset worn, display turned off. This will act as a baseline for intervention 2 and 3

OTHER

Virtual Reality Headset, Display only

15 minutes of EEG recording with VR headset worn, display turned on without access to hand controls.

OTHER

Virtual Reality Headset, Display and Hand Control

15 minutes of EEG recording with VR headset worn, display turned on with access to hand controls

Sponsors & Collaborators

  • Dartmouth-Hitchcock Medical Center

    lead OTHER

Principal Investigators

  • Jared E Quast, MD · Dartmouth-Hitchcock Medical Center

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
13 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-06-30
Primary Completion
2027-06-30
Completion
2027-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07451093 on ClinicalTrials.gov